To amend the Federal Food, Drug, and Cosmetic Act to permanently extend the authority of the Secretary of Health and Human Services to award priority review vouchers for rare pediatric disease products.
introducedSign in to watch / set alerts
TQL analysis
C68
68 / 90 · methodology full_text_v3
The bill aims to amend the Federal Food, Drug, and Cosmetic Act to permanently extend the authority of the Secretary of Health and Human Services to award priority review vouchers for rare pediatric disease products. It involves a straightforward amendment by striking a specific paragraph, with no additional provisions or funding mechanisms included.
Legislative structure
Criterion breakdown8 criteria · max 90
Advanced Full criterion breakdown
The letter, score, and explanation above are free. The point-by-point breakdown of all eight scored criteria — with each criterion's value and how it moved the grade — is a Quiet Ledger research capability.
Access options →Actions (3)
| Date | Time | Action |
|---|---|---|
| 2026-09-14 | — | Referred to the House Committee on Energy and Commerce. |
| 2026-09-14 | — | Introduced in House |
| 2026-09-14 | — | Introduced in House |
Provenance
- Methodology
- full_text_v3
- Calculated
- 2026-09-18 17:01:35.312+00
- Source version
- 2026-09-14
- Assessments
- —
The Quiet Ledger grades legislation on its content. A bill grade is analysis of the bill — not a grade of its sponsor or of any member who voted on it.